Quantcast
Last updated on April 18, 2014 at 11:15 EDT

Latest Oncology Stories

2014-03-24 23:23:11

The Foundation for Women’s Cancer and the Claudia Cohen Research Foundation announce today that Dr. Andrew Berchuck has been selected as the 2014 recipient of the Foundation for Women’s Cancer/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 prize is being presented at the Society of Gynecologic Oncology 45th Annual Meeting on Women's Cancer in Tampa. Tampa, FL (PRWEB) March 24, 2014 The Foundation for Women’s Cancer and the Claudia...

2014-03-24 16:24:20

Asbestos Disease Awareness Organization Celebrates 10 Years with 10th Annual International Asbestos Awareness Conference ALTON, Ill., March 24, 2014 /PRNewswire/ -- The Simmons Law Firm, a nationwide leader in mesothelioma and asbestos litigation, has renewed its commitment to support asbestos awareness in the United States and beyond as a Platinum Sponsor of the "Where Knowledge and Action Unite" 10(th) Annual International Asbestos Awareness Conference. (Photo:...

2014-03-24 12:30:19

Largest Study of Its Kind Shows Minimally Invasive Treatment May Slow Disease Progression in Liver While Maintaining Quality of Life SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology's 39th Annual...

2014-03-24 08:28:31

PRINCETON, N.J., March 24, 2014 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and Guerbet S.A. (GBT.PA) are pleased to announce today that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer. The objective of the collaboration is to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers*....

2014-03-24 08:27:56

Foremost research organization uses Web of Science to evaluate and enhance funding decisions PHILADELPHIA, March 24, 2014 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced a collaboration with Susan G. Komen®, the world's largest breast cancer organization. As part of this relationship, Susan G. Komen will have special access to Thomson Reuters...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...

2014-03-22 23:04:05

Pretty In Pink Foundation achieves business milestone while providing hope and healing to underinsured and uninsured North Carolinians diagnosed with breast cancer Raleigh, NC (PRWEB) March 22, 2014 Headquartered in Raleigh, North Carolina under the leadership of its Founder Dr. Lisa Tolnitch, Pretty In Pink Foundation (http://www.prettyinpinkfoundation.org) proudly celebrates ten years of serving North Carolinian women and men diagnosed with breast cancer who are unable to pay for...

2014-03-22 20:20:22

Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of Dermatology DENVER, March 22, 2014 /PRNewswire/ -- Castle Biosciences Inc. today announced study results showing its gene expression profile (GEP) test (DecisionDx-Melanoma) can identify primary cutaneous (skin) melanoma tumors that are likely to metastasize in patients who had a negative sentinel lymph node biopsy. The data are being presented at the Latest in...

Mammograms Needed More Often For One-Third Of Women
2014-03-22 07:07:50

April Flowers for redOrbit.com - Your Universe Online While three-year intervals between mammograms are appropriate for most women, a new study from the UK NHS Breast Screening Program has found that one-third of women are at a higher risk of developing cancer. These women, according to the report delivered this week at the 9th European Breast Cancer Conference (EBCC-9), might benefit from more frequent mammograms. Professor Gareth Evans, from the University of Manchester, reported that...

2014-03-21 23:25:31

The Mesothelioma Victims Center wants to explain to every diagnosed victim of mesothelioma, or their family members, how incredibly vital it is to have a properly executed will, and a very responsible family member assigned with power of attorney, because of the chaos that can break out in the family if these things are not in place. For more information diagnosed victims of mesothelioma, or their family members are urged to contact the Mesothelioma Victims Center anytime at 866-714-6466....